{"transactions":[{"id":3137697,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":148997,"kind":"person","name":"Noiman Silvia","position":1,"cik":"0001340877","reported_name":"Noiman Silvia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-22T20:10:24.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one half (1/2) of the shares underlying the option shall vest on May 20, 2021 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":3.39,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-20-001300","document":"form4-05222020_040510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920001300/form4-05222020_040510.xml","form_type":"4"}},{"id":3509088,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":148997,"kind":"person","name":"Noiman Silvia","position":1,"cik":"0001340877","reported_name":"Noiman Silvia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-29T21:22:47.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half (1/2) of the shares underlying the option shall vest on May 29, 2020 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":9.02,"expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-19-000627","document":"form4-05292019_020533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000627/form4-05292019_020533.xml","form_type":"4"}},{"id":3880653,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":148997,"kind":"person","name":"Noiman Silvia","position":1,"cik":"0001340877","reported_name":"Noiman Silvia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-29T20:12:00.000Z","date":"2018-06-06","kind":"exercise","acquired":false,"shares":349400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The option was issued pursuant to the Company's Eloxx Pharmaceuticals Ltd. Share Ownership and Option Plan (2013) and was priced at Israeli New Shekel 0.0020. This amount reflects the U.S. dollar equivalent of the exercise price as of the transaction date using an exchange rate of 1:3.5736, as reported by Bloomberg."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully vested and exercisable as of October 26, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.0006,"expiration_date":"2024-04-26","underlying":"Common Stock","underlying_shares":349400},"source":{"system":"sec-edgar","filing":"0001209191-18-040022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118040022/doc4.xml","form_type":"4"}},{"id":3880652,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":148997,"kind":"person","name":"Noiman Silvia","position":1,"cik":"0001340877","reported_name":"Noiman Silvia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-06-29T20:12:00.000Z","date":"2018-06-06","kind":"exercise","acquired":true,"shares":349400,"price":0.0006,"value":209.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was issued pursuant to the Company's Eloxx Pharmaceuticals Ltd. Share Ownership and Option Plan (2013) and was priced at Israeli New Shekel 0.0020. This amount reflects the U.S. dollar equivalent of the exercise price as of the transaction date using an exchange rate of 1:3.5736, as reported by Bloomberg."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the total number of shares owned by the Reporting Person as of the date of filing."}],"balance_after":490789,"source":{"system":"sec-edgar","filing":"0001209191-18-040022","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118040022/doc4.xml","form_type":"4"}},{"id":3889179,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":148997,"kind":"person","name":"Noiman Silvia","position":1,"cik":"0001340877","reported_name":"Noiman Silvia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-19T22:15:07.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half (1/2) of the shares underlying the option shall vest on June 15, 2019 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":40000,"derivative":{"exercise_price":23.27,"expiration_date":"2028-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-038658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118038658/doc4.xml","form_type":"4"}},{"id":3889178,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":148997,"kind":"person","name":"Noiman Silvia","position":1,"cik":"0001340877","reported_name":"Noiman Silvia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-19T22:15:07.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":141389,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":141389,"derivative":{"exercise_price":23.27,"exercise_date":"2018-06-15","expiration_date":"2028-06-15","underlying":"Common Stock","underlying_shares":141389},"source":{"system":"sec-edgar","filing":"0001209191-18-038658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118038658/doc4.xml","form_type":"4"}},{"id":3889177,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":148997,"kind":"person","name":"Noiman Silvia","position":1,"cik":"0001340877","reported_name":"Noiman Silvia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-06-19T22:15:07.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":141389,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":141389,"source":{"system":"sec-edgar","filing":"0001209191-18-038658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118038658/doc4.xml","form_type":"4"}}]}